Surprisingly, both novel MAO-B inhibitors markedly reduced glioma cell migration, thus significantly preventing the invasiveness of brain tumors and their ability to infiltrate the neighbouring tissues as already demonstrated for several anti-glioma agents [24,25]. The gene discussed is MAOB; the disease is glioma.